Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD40 antibody (Extracellular Domain)

This Mouse Monoclonal antibody specifically detects CD40 in BR. It exhibits reactivity toward Human.
Catalog No. ABIN7072684
$624.00
Plus shipping costs $50.00
200 μg
Shipping to: United States
Delivery in 7 to 13 Business Days

Quick Overview for Recombinant CD40 antibody (Extracellular Domain) (ABIN7072684)

Target

See all CD40 Antibodies
CD40

Antibody Type

Recombinant Antibody

Reactivity

  • 270
  • 132
  • 20
  • 19
  • 8
  • 6
  • 6
  • 6
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Human

Host

  • 150
  • 111
  • 72
  • 32
  • 5
  • 2
  • 1
  • 1
Mouse

Clonality

  • 267
  • 98
  • 7
Monoclonal

Conjugate

  • 186
  • 33
  • 27
  • 18
  • 18
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD40 antibody is un-conjugated

Application

  • 215
  • 102
  • 75
  • 73
  • 41
  • 34
  • 31
  • 20
  • 19
  • 17
  • 14
  • 13
  • 11
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Blocking Reagent (BR)

Clone

Chi220
  • Binding Specificity

    • 21
    • 19
    • 18
    • 17
    • 16
    • 15
    • 14
    • 9
    • 9
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Purpose

    Anti-CD40 [chi220], Mouse IgG2a, kappa

    Specificity

    This antibody binds the CD40 and blocks the humoral immune responses to T cell dependent antigens in a dose dependent manner.

    Characteristics

    Original Species of Ab: Mouse

    Original Format of Ab: IgG2a

    Purification

    Protein A affinity purified

    Immunogen

    This antibody was generated by immunizing female BALB/c mice with a fusion protein containing extracellular domain of human CD40 fused to the hinge CH2 and CH3 domains of a murine IgG2b antibody.

    Isotype

    IgG2a kappa
  • Application Notes

    This antibody blocks the interaction between CD40 and gp39. Chi220 was used either alone or in combination with CTLA4-Ig in an immunosuppresive therapy study to check the survival of renal allografts in non human primate models (PMID: 12394833). Chi220 blocks binding of CD154, it also has partial agonist properties and weak stimulatory potential. It synergisticaly works with LEA29Y (belatacept) to prolong the islet allograft survival in a non-human primate Macaca fascicularis (PMID: 15611281). A study on protection of islets xenographs in diabetic macaques used a combination of Chi220 with IL-2 receptor specific antibody Basiliximab for immunosuppression with induction therapy. Chi220 is used as an sCD154 blocking agent and it was seen that it binds sCD154 in a dose dependant manner (PMID: 21920020). Two humanized versions of this antibody were generated F4 and L3.17, also showed similar properties. Humanized versions of this antibody are available on request.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    CD40

    Alternative Name

    CD40

    Background

    TNFSF5, CDw40, TRAP, p50, Bp50, CD40L receptor, Tumor necrosis factor ligand superfamily member 5, B-cell surface antigen CD40, T-cell antigen Gp39, TNF-related activation protein.

    UniProt

    P29965

    Pathways

    NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
You are here:
Chat with us!